Column 1 Column 2 Column 3 Column 4 0 B2 M2 S2 1 Commenced operations Sep-17 Nov-17 1Q19 2 MW built1 (MW) 2.0 2.0 - 3 Contracted utilisation (MW)
% of total power planned
% of MW built0.2
2%
11%0.3
1%
16%5.4
18%
-
As we know, Billing Utilisation is MW actually bringing in $Revenue. Contracted Utilisation is a bit of a leading indicator to this.
It's interesting given how far out S2 is in comparison to M2, yet M2 has no/little Contracted Utilisation.
S1 Observations:
It's also interesting to me the level of Project Revenue over the last 12months is >$8M.
It's interesting to me how Contracted & Billing Utilisation have both jumped a large amount and are suddenly in lock step. Contracted Utilisation is suddenly 94%/Billing 92%.
My theory,
The results are largely affected by the results of a major project rolling through.
That the major project is Microsoft on the back of Azure/Office 365 Success.
Microsoft makes up a big portion of the forward Contracted Utilisation for S2.
- Forums
- ASX - By Stock
- NXT
- Ann: Half Year Results Announcement
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

Ann: Half Year Results Announcement, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online